- Home
- CTNM vs SSSS Comparison
CTNM vs SSSS Comparison
Compare CTNM & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- SSSS
- Stock Information
- Founded
- CTNM 2009
- SSSS 2010
- Country
- CTNM United States
- SSSS United States
- Employees
- CTNM N/A
- SSSS N/A
- Industry
- CTNM
- SSSS Finance: Consumer Services
- Sector
- CTNM
- SSSS Finance
- Exchange
- CTNM Nasdaq
- SSSS Nasdaq
- Market Cap
- CTNM 122.9M
- SSSS 138.2M
- IPO Year
- CTNM 2024
- SSSS N/A
- Fundamental
- Price
- CTNM $3.84
- SSSS $8.21
- Analyst Decision
- CTNM Strong Buy
- SSSS Strong Buy
- Analyst Count
- CTNM 4
- SSSS 3
- Target Price
- CTNM $22.50
- SSSS $8.67
- AVG Volume (30 Days)
- CTNM 222.5K
- SSSS 369.3K
- Earning Date
- CTNM 08-12-2025
- SSSS 08-06-2025
- Dividend Yield
- CTNM N/A
- SSSS N/A
- EPS Growth
- CTNM N/A
- SSSS N/A
- EPS
- CTNM N/A
- SSSS N/A
- Revenue
- CTNM N/A
- SSSS $3,644,430.00
- Revenue This Year
- CTNM N/A
- SSSS $5,400.03
- Revenue Next Year
- CTNM N/A
- SSSS N/A
- P/E Ratio
- CTNM N/A
- SSSS N/A
- Revenue Growth
- CTNM N/A
- SSSS N/A
- 52 Week Low
- CTNM $3.35
- SSSS $3.52
- 52 Week High
- CTNM $22.00
- SSSS $8.77
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- SSSS 77.74
- Support Level
- CTNM N/A
- SSSS $7.26
- Resistance Level
- CTNM N/A
- SSSS $8.77
- Average True Range (ATR)
- CTNM 0.00
- SSSS 0.30
- MACD
- CTNM 0.00
- SSSS 0.03
- Stochastic Oscillator
- CTNM 0.00
- SSSS 77.11
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.